Former Chiron exec named APT CEO
Executive Summary
Former Chiron Chief Medical Officer Stephen Dilly is named CEO of APT Pharmaceuticals, the company announces Sept. 6. Prior to working at Chiron, Dilly served as VP-clinical R&D and medical affairs at Genentech and also held executive positions with SmithKline Beecham and Pfizer...